Innate Pharma S.A.Innate Pharma S.A.Innate Pharma S.A.

Innate Pharma S.A.

No trades
See on Supercharts

Price target

7.230.000.00%
The 6 analysts offering 1 year price forecasts for IPHA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to IPHA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned